1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019). (September 2015) - Chapman, H.; Bloomfield, D.; Cameron, D.; Bliss, J.; Barrett-Lee, P.; Canney, P.; Morden, J.; Velikova, G.; Hall, P.